[Federal Register Volume 70, Number 239 (Wednesday, December 14, 2005)]
[Notices]
[Page 74024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-24015]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the NIH Advisory Board for Clinical Research.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set froth in section 552b(c)(6), Title 5 U.S.C., as amended 
for discussion of personal qualifications and performance, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: NIH Advisory Board for Clinical Research.
    Date: January 30, 2006.
    Open: 10 a.m. to 1:30 p.m.
    To review the Clinical Center operating plan, ABCR workgroups 
and Budgetary issues.
    National Institutes of Health, Building 10, 10 Center Drive, 4-
2551, CRC Medical Board Room, Bethesda, MD 20892.
    Closed: 1:30 p.m. to 2 p.m.
    Agenda: To review and evaluate for discussion of personal 
qualifications and performance the disclosure of which constitute a 
clearly unwarranted invasion of privacy.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892.
    Contact Person: Maureen E. Gormley, Executive Secretary, Mark O. 
Hatfield Clinical Research Center, National Institutes of Health, 
Building 10, Room 6-15610, Bethesda MD 20892, 301/496-2897.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: December 7, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-24015 Filed 12-13-05; 8:45am]
BILLING CODE 4140-01-M